Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 363K | 1.42M | 3.8M | 5.26M | 5.65M | 5.21M | 11.53M | 15.89M | 14.77M | 25.41M | 30.69M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.15M | 12.15M | 7.5M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | -19.46M | 829K | 854K | 875K | 897K | 944K | 963K | 979K | 455K | 520K |
Receivables | n/a | n/a | n/a | 335K | 313K | 616K | 608K | 542K | 422K | 219K | 163K |
Inventory | n/a | n/a | n/a | n/a | 4.48M | 5.25M | 5.21M | 5M | 4.31M | 3.56M | 2.77M |
Other Current Assets | 975K | 444K | 305K | 753K | 832K | 1.4M | 2.37M | 2.06M | 1.48M | 1.95M | 2.57M |
Total Current Assets | 1.34M | 1.86M | 4.11M | 6.35M | 11.27M | 12.48M | 19.72M | 23.49M | 31.14M | 43.28M | 43.69M |
Property-Plant & Equipment | 6.55M | 6.72M | 1K | 704K | 1.24M | 4.94M | 4.99M | 5.01M | 4.93M | 4.98M | 5.04M |
Goodwill & Intangibles | 12.7M | 12.74M | 2.13M | 2.13M | 4.13M | 22.52M | 23.16M | 23.8M | 24.45M | 25.09M | 25.74M |
Total Long-Term Assets | 19.25M | 19.46M | 2.96M | 3.69M | 6.24M | 28.36M | 29.1M | 29.78M | 30.36M | 30.53M | 31.3M |
Total Assets | 20.58M | 21.32M | 7.07M | 10.03M | 17.51M | 40.83M | 48.81M | 53.28M | 61.5M | 73.81M | 74.99M |
Account Payables | 7.82M | 5.83M | 3.84M | 3.93M | 3.61M | 3.06M | 3.28M | 1.47M | 1.82M | 2.08M | 1.14M |
Deferred Revenue | n/a | 2.49M | n/a | n/a | n/a | n/a | n/a | 5.54M | 3.32M | 3.88M | 3.39M |
Short-Term Debt | 5.57M | 6.47M | 6M | 5.6M | 5.91M | 3.61M | 3.06M | 2.22M | 1.39M | 555K | 1.2M |
Other Current Liabilities | 5.66M | 8.15M | 2.53M | 11.93M | 11.76M | 11.51M | 14.06M | 11.96M | 11.23M | 11.18M | 11.79M |
Total Current Liabilities | 19.05M | 20.46M | 12.37M | 21.46M | 21.27M | 18.18M | 20.4M | 15.65M | 14.44M | 13.82M | 14.12M |
Long-Term Debt | 2.53M | 2.3M | 1.43M | 1.52M | 2.17M | 5.1M | 5.71M | 6.31M | 6.91M | 7.52M | 8.19M |
Other Long-Term Liabilities | 9.04M | 9.04M | 574K | 11.29M | 13.6M | 13.32M | 12.97M | 18.1M | 60.87M | 57.04M | 53.67M |
Total Long-Term Liabilities | 11.77M | 11.54M | 2.01M | 12.81M | 15.78M | 18.42M | 18.67M | 24.41M | 67.78M | 64.56M | 61.86M |
Total Liabilities | 30.82M | 32M | 14.38M | 34.27M | 37.05M | 36.6M | 39.07M | 40.05M | 82.23M | 78.38M | 75.98M |
Total Debt | 8.1M | 8.77M | 7.43M | 7.12M | 8.09M | 8.71M | 8.76M | 8.53M | 8.3M | 8.07M | 9.38M |
Common Stock | 122K | 70K | 26K | 16K | 200K | 81K | 64K | 983K | 844K | 843K | 701K |
Retained Earnings | -189.3M | -186.88M | -179.5M | -190.9M | -181.65M | -152.43M | -144.9M | -132.09M | -161.52M | -144.56M | -129.23M |
Comprehensive Income | n/a | -9.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.33M |
Shareholders Equity | -10.24M | -10.68M | -7.31M | -24.24M | -19.54M | 4.23M | 9.74M | 13.23M | -20.73M | -4.57M | -994K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.15M | 12.15M | 7.5M |